These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 39000441)

  • 1. Differential Immune Checkpoint Protein Expression in HNSCC: The Role of HGF/MET Signaling.
    Boschert V; Boenke J; Böhm AK; Teusch J; Steinacker V; Straub A; Hartmann S
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings.
    Boschert V; Teusch J; Aljasem A; Schmucker P; Klenk N; Straub A; Bittrich M; Seher A; Linz C; Müller-Richter UDA; Hartmann S
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of the HGF/Met signaling in head and neck squamous cell carcinoma: Focus on tumor immunity (Review).
    Liu D; Zhong M; Zhan D; Zhang Y; Liu S
    Oncol Rep; 2020 Dec; 44(6):2337-2344. PubMed ID: 33125120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR9 Mediated Tumor-Stroma Interactions in Human Papilloma Virus (HPV)-Positive Head and Neck Squamous Cell Carcinoma Up-Regulate PD-L1 and PD-L2.
    Baruah P; Bullenkamp J; Wilson POG; Lee M; Kaski JC; Dumitriu IE
    Front Immunol; 2019; 10():1644. PubMed ID: 31379843
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune checkpoint molecules are regulated by transforming growth factor (TGF)-
    Shrestha R; Bridle KR; Crawford DHG; Jayachandran A
    Int J Med Sci; 2021; 18(12):2466-2479. PubMed ID: 34104078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of immune checkpoint proteins PD-L1 and TIM3 in mouse and human head and neck squamous cell carcinoma.
    Elmusrati A; Wang CY
    Eur J Oral Sci; 2024 Oct; 132(5):e13010. PubMed ID: 39090710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMTM4 regulates epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinoma.
    Li H; Liu YT; Chen L; Zhou JJ; Chen DR; Li SJ; Sun ZJ
    Mol Carcinog; 2021 Aug; 60(8):556-566. PubMed ID: 34061408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.
    Knowles LM; Stabile LP; Egloff AM; Rothstein ME; Thomas SM; Gubish CT; Lerner EC; Seethala RR; Suzuki S; Quesnelle KM; Morgan S; Ferris RL; Grandis JR; Siegfried JM
    Clin Cancer Res; 2009 Jun; 15(11):3740-50. PubMed ID: 19470725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy.
    Xu Y; Gao Z; Hu R; Wang Y; Wang Y; Su Z; Zhang X; Yang J; Mei M; Ren Y; Li M; Zhou X
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34697216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting CMTM6 Suppresses Stem Cell-Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma.
    Chen L; Yang QC; Li YC; Yang LL; Liu JF; Li H; Xiao Y; Bu LL; Zhang WF; Sun ZJ
    Cancer Immunol Res; 2020 Feb; 8(2):179-191. PubMed ID: 31771985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma.
    Susuki D; Kimura S; Naganuma S; Tsuchiyama K; Tanaka T; Kitamura N; Fujieda S; Itoh H
    Cancer Sci; 2011 Dec; 102(12):2164-71. PubMed ID: 21899661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in Head and Neck Squamous Cell Carcinoma.
    Lin W; Xu Y; Gao J; Zhang H; Sun Y; Qiu X; Huang Q; Kong L; Lu JJ
    Front Immunol; 2021; 12():757047. PubMed ID: 34675936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling the regulatory mechanism of nimotuzumab on PD-L1 expression in head and neck squamous cell carcinoma patients: Implications for enhanced anticancer treatment strategies.
    Hu M; Tang B; Dai Y; Zhao X
    Cell Signal; 2024 Sep; 121():111290. PubMed ID: 38977231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression level of PD-L1 is involved in ALDH1A1-mediated poor prognosis in patients with head and neck squamous cell carcinoma.
    Zhou AL; Wang X; Yu W; Yang L; Wei F; Sun Q; Wang Y; Kou F; Dong R; Ren X; Zhang X
    Pathol Res Pract; 2020 Sep; 216(9):153093. PubMed ID: 32825960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 Influences Cell Spreading, Migration and Invasion in Head and Neck Cancer Cells.
    Eichberger J; Schulz D; Pscheidl K; Fiedler M; Reichert TE; Bauer RJ; Ettl T
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33138288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The polymorphism rs975484 in the protein arginine methyltransferase 1 gene modulates expression of immune checkpoint genes in hepatocellular carcinoma.
    Schonfeld M; Zhao J; Komatz A; Weinman SA; Tikhanovich I
    J Biol Chem; 2020 May; 295(20):7126-7137. PubMed ID: 32245889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing.
    Kürten CHL; Kulkarni A; Cillo AR; Santos PM; Roble AK; Onkar S; Reeder C; Lang S; Chen X; Duvvuri U; Kim S; Liu A; Tabib T; Lafyatis R; Feng J; Gao SJ; Bruno TC; Vignali DAA; Lu X; Bao R; Vujanovic L; Ferris RL
    Nat Commun; 2021 Dec; 12(1):7338. PubMed ID: 34921143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma.
    Boschert V; Klenk N; Abt A; Janaki Raman S; Fischer M; Brands RC; Seher A; Linz C; Müller-Richter UDA; Bischler T; Hartmann S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix.
    Zong L; Zhang Q; Zhou Y; Kong Y; Yu S; Chen J; Zhang Y; Xiang Y
    J Immunol Res; 2020; 2020():1283632. PubMed ID: 32322590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and phosphorylation of Stathmin 1 indicate poor survival in head and neck squamous cell carcinoma and associate with immune suppression.
    Wu H; Deng WW; Yang LL; Zhang WF; Sun ZJ
    Biomark Med; 2018 Jul; 12(7):759-769. PubMed ID: 29847156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.